C0151
Colorectal cancer Panel
Number of Tests | 7 |
Test Included | KRAS, NRAS, BRAF |
Test Details: This panel detecting tumor-associated somatic mutations in 3 different oncogenes can predict response to EGFR-targeted immunotherapy in patients with metastatic colorectal cancer. Tumors with mutations in KRAS, NRAS and BRAF are associated with inferior response to anti-EGFR immunotherapy and variably associated with more aggressive clinical behaviour compared to unmutated cases.
![](assets/img/diagnleftimg.png)
Category
Molecular Genetics
Pre-test Information
Clinical history, histopathology report are mandatory.
Report Delivery
7 working days
Gender
All
Organ
Digestive / Gastrointestinal
Colorectal cancer Panel
10000
Most Searched Diagnostic Tests